FSTX Insider Transactions
Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
---|---|---|---|---|---|---|---|---|
2023-03-08 | Kayitalire Louis | officer: CHIEF MEDICAL OFFICER | 25,019 | U-Tender | D | 29,236 | 7.12 | 208,160.00 |
2023-03-08 | Kayitalire Louis | officer: CHIEF MEDICAL OFFICER | 0 | D-Return | D | 25,019 | 7.12 | 178,135.00 |
2023-03-08 | Kayitalire Louis | officer: CHIEF MEDICAL OFFICER | 0 | D-Return | D | 27,289 | 16.62 | 453,543.00 |
2023-03-08 | Kayitalire Louis | officer: CHIEF MEDICAL OFFICER | 0 | D-Return | D | 12,880 | 7.24 | 93,251.00 |
2023-03-08 | Kayitalire Louis | officer: CHIEF MEDICAL OFFICER | 0 | D-Return | D | 53,634 | 4.77 | 255,834.00 |
2023-03-08 | Kayitalire Louis | officer: CHIEF MEDICAL OFFICER | 0 | D-Return | D | 35,719 | 3.55 | 126,802.00 |
2023-03-08 | Forster Eliot | director, officer: PRESIDENT AND CEO | 73,959 | U-Tender | D | 347,578 | 7.12 | 2,474,755.00 |
2023-03-08 | Forster Eliot | director, officer: PRESIDENT AND CEO | 0 | D-Return | D | 73,959 | 7.12 | 526,588.00 |
2023-03-08 | Forster Eliot | director, officer: PRESIDENT AND CEO | 0 | D-Return | D | 127,924 | 7.24 | 926,170.00 |
2023-03-08 | Forster Eliot | director, officer: PRESIDENT AND CEO | 0 | D-Return | D | 165,028 | 4.77 | 787,184.00 |
2023-03-08 | Forster Eliot | director, officer: PRESIDENT AND CEO | 0 | D-Return | D | 126,909 | 3.55 | 450,527.00 |
2023-03-08 | Klein Pamela M. | director | 0 | D-Return | D | 20,000 | 6.88 | 137,600.00 |
2023-03-08 | Klein Pamela M. | director | 0 | D-Return | D | 20,000 | 3.41 | 68,200.00 |
2020-11-20 | Klein Pamela M. | director | 0 | J-Other | D | 15,000 | 4.62 | 69,300.00 |
2020-11-20 | Klein Pamela M. | director | 0 | J-Other | D | 7,500 | 1.60 | 12,000.00 |
2023-03-08 | DEPTULA-HICKS DARLENE M | officer: See Remarks | 25,539 | U-Tender | D | 30,898 | 7.12 | 219,994.00 |
2023-03-08 | DEPTULA-HICKS DARLENE M | officer: See Remarks | 0 | D-Return | D | 25,539 | 7.12 | 181,838.00 |
2023-03-08 | DEPTULA-HICKS DARLENE M | officer: See Remarks | 0 | D-Return | D | 28,426 | 16.62 | 472,440.00 |
2023-03-08 | DEPTULA-HICKS DARLENE M | officer: See Remarks | 0 | D-Return | D | 25,894 | 7.34 | 190,062.00 |
2023-03-08 | DEPTULA-HICKS DARLENE M | officer: See Remarks | 0 | D-Return | D | 59,823 | 4.77 | 285,356.00 |
2023-03-08 | DEPTULA-HICKS DARLENE M | officer: See Remarks | 0 | D-Return | D | 24,902 | 3.55 | 88,402.00 |
2023-03-08 | Brady Todd C | director | 0 | U-Tender | D | 15,004 | 7.12 | 106,828.00 |
2023-03-08 | Brady Todd C | director | 0 | D-Return | D | 20,000 | 6.88 | 137,600.00 |
2023-03-08 | Brady Todd C | director | 0 | D-Return | D | 20,000 | 3.41 | 68,200.00 |
2020-11-20 | Brady Todd C | director | 0 | J-Other | D | 11,000 | 9.05 | 99,550.00 |
2020-11-20 | Brady Todd C | director | 0 | J-Other | D | 10,964 | 10.79 | 118,302.00 |
2020-11-20 | Brady Todd C | director | 0 | J-Other | D | 5,500 | 14.27 | 78,485.00 |
2020-11-20 | Brady Todd C | director | 0 | J-Other | D | 5,500 | 13.99 | 76,945.00 |
2020-11-20 | Brady Todd C | director | 0 | J-Other | D | 7,500 | 4.62 | 34,650.00 |
2020-11-20 | Brady Todd C | director | 0 | J-Other | D | 7,500 | 1.60 | 12,000.00 |
2023-03-08 | Brewis Neil | officer: CHIEF SCIENTIFIC OFFICER | 9,375 | U-Tender | D | 105,088 | 7.12 | 748,227.00 |
2023-03-08 | Brewis Neil | officer: CHIEF SCIENTIFIC OFFICER | 0 | D-Return | D | 9,375 | 7.12 | 66,750.00 |
2023-03-08 | Brewis Neil | officer: CHIEF SCIENTIFIC OFFICER | 0 | D-Return | D | 22,561 | 7.24 | 163,342.00 |
2023-03-08 | Brewis Neil | officer: CHIEF SCIENTIFIC OFFICER | 0 | D-Return | D | 74,263 | 4.77 | 354,235.00 |
2023-03-08 | Brewis Neil | officer: CHIEF SCIENTIFIC OFFICER | 0 | D-Return | D | 132,469 | 3.55 | 470,265.00 |
2023-03-08 | Race Geoffrey | director | 0 | U-Tender | D | 3,937 | 7.12 | 28,031.00 |
2023-03-08 | Race Geoffrey | director | 0 | D-Return | D | 20,000 | 6.88 | 137,600.00 |
2023-03-08 | Race Geoffrey | director | 0 | D-Return | D | 20,000 | 3.41 | 68,200.00 |
2023-03-08 | Bermingham Nessan | director | 6,328 | U-Tender | D | 97,547 | 7.12 | 694,535.00 |
2023-03-08 | Bermingham Nessan | director | 0 | D-Return | D | 20,000 | 6.88 | 137,600.00 |
2023-03-08 | Bermingham Nessan | director | 0 | D-Return | D | 6,328 | 7.12 | 45,055.00 |
2023-03-08 | Bermingham Nessan | director | 0 | D-Return | D | 34,111 | 16.62 | 566,925.00 |
2023-03-08 | Bermingham Nessan | director | 0 | D-Return | D | 20,000 | 3.41 | 68,200.00 |
2023-03-08 | Benz Edward JR | director | 0 | D-Return | D | 4,385 | 7.12 | 31,221.00 |
2023-03-08 | Benz Edward JR | director | 0 | D-Return | D | 3,937 | 14.31 | 56,338.00 |
2023-03-08 | Benz Edward JR | director | 0 | D-Return | D | 20,000 | 6.88 | 137,600.00 |
2023-03-08 | Benz Edward JR | director | 0 | D-Return | D | 20,000 | 3.41 | 68,200.00 |
2020-11-20 | Arkowitz David | director | 0 | J-Other | D | 5,500 | 9.05 | 49,775.00 |
2023-03-08 | Arkowitz David | director | 0 | U-Tender | D | 8,386 | 7.12 | 59,708.00 |
2023-03-08 | Arkowitz David | director | 0 | D-Return | D | 20,000 | 6.88 | 137,600.00 |
2023-03-08 | Arkowitz David | director | 0 | D-Return | D | 20,000 | 3.41 | 68,200.00 |
2020-11-20 | Arkowitz David | director | 0 | J-Other | D | 10,000 | 9.28 | 92,800.00 |
2020-11-20 | Arkowitz David | director | 0 | J-Other | D | 4,386 | 10.79 | 47,325.00 |
2020-11-20 | Arkowitz David | director | 0 | J-Other | D | 5,500 | 14.27 | 78,485.00 |
2020-11-20 | Arkowitz David | director | 0 | J-Other | D | 5,500 | 13.99 | 76,945.00 |
2020-11-20 | Arkowitz David | director | 0 | J-Other | D | 7,500 | 4.62 | 34,650.00 |
2020-11-20 | Arkowitz David | director | 0 | J-Other | D | 7,500 | 1.60 | 12,000.00 |
2022-07-29 | Race Geoffrey | director | 3,937 | M-Exempt | D | 3,937 | 0.00 | 0.00 |
2022-07-29 | Forster Eliot | officer: President and CEO | 0 | M-Exempt | D | 228,375 | 0.00 | 0.00 |
2022-07-29 | Brewis Neil | officer: Chief Scientific Officer | 114,463 | M-Exempt | A | 76,619 | 0.11 | 8,428.00 |
2022-07-29 | Brewis Neil | officer: Chief Scientific Officer | 0 | M-Exempt | D | 70,312 | 0.00 | 0.00 |
2022-07-29 | Brewis Neil | officer: Chief Scientific Officer | 0 | M-Exempt | D | 70,312 | 0.11 | 7,734.00 |
2022-06-17 | Brady Todd C | director: | 20,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
2022-06-17 | Brady Todd C | director | 20,000 | A-Award | A | 20,000 | 3.41 | 68,200.00 |
2022-06-17 | Race Geoffrey | director: | 20,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
2022-06-17 | Benz Edward JR | director: | 20,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
2022-06-17 | Benz Edward JR | director | 20,000 | A-Award | A | 20,000 | 3.41 | 68,200.00 |
2022-06-17 | Klein Pamela M. | director: | 20,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
2022-06-17 | Klein Pamela M. | director | 20,000 | A-Award | A | 20,000 | 3.41 | 68,200.00 |
2022-06-17 | Bermingham Nessan | director: | 20,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
2022-06-17 | Bermingham Nessan | director | 20,000 | A-Award | A | 20,000 | 3.41 | 68,200.00 |
2022-06-17 | Arkowitz David | director: | 20,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
2022-06-17 | Arkowitz David | director | 20,000 | A-Award | A | 20,000 | 3.41 | 68,200.00 |
2022-03-31 | Forster Eliot | officer: President and CEO | 126,909 | A-Award | A | 126,909 | 0.00 | 0.00 |
2022-03-31 | DEPTULA-HICKS DARLENE M | officer: Treasurer and CFO | 24,902 | A-Award | A | 24,902 | 0.00 | 0.00 |
2022-03-31 | Kayitalire Louis | officer: Chief Medical Officer | 35,719 | A-Award | A | 35,719 | 0.00 | 0.00 |
2022-03-31 | Kayitalire Louis | officer: Chief Medical Officer | 35,719 | A-Award | A | 35,719 | 3.55 | 126,802.00 |
2022-03-31 | Brewis Neil | officer: Chief Scientific Officer | 132,469 | A-Award | A | 132,469 | 0.00 | 0.00 |
2022-03-31 | Brewis Neil | officer: Chief Scientific Officer | 132,469 | A-Award | A | 132,469 | 3.55 | 470,265.00 |
2022-01-09 | Kayitalire Louis | officer: Chief Medical Officer | 53,634 | A-Award | A | 53,634 | 4.77 | 255,834.00 |
2022-01-09 | DEPTULA-HICKS DARLENE M | officer: Treasurer and CFO | 59,823 | A-Award | A | 59,823 | 4.77 | 285,356.00 |
2022-01-09 | Brewis Neil | officer: Chief Scientific Officer | 74,263 | A-Award | A | 74,263 | 4.77 | 354,235.00 |
2022-01-09 | Forster Eliot | director, officer: President and CEO | 165,028 | A-Award | A | 165,028 | 4.77 | 787,184.00 |
2021-11-02 | Kayitalire Louis | officer: Chief Medical Officer | 54,280 | S-Sale | D | 39 | 6.81 | 265.60 |
2021-11-02 | Kayitalire Louis | officer: Chief Medical Officer | 54,255 | S-Sale | D | 25 | 6.85 | 171.20 |
2021-10-04 | Kayitalire Louis | officer: Chief Medical Officer | 54,319 | S-Sale | D | 64 | 7.23 | 462.40 |
2020-11-20 | Bermingham Nessan | director | 16,875 | A-Award | A | 16,875 | 0.00 | 0.00 |
2020-11-20 | DEPTULA-HICKS DARLENE M | officer: Treasurer and CFO | 26,437 | A-Award | A | 26,437 | 0.00 | 0.00 |
2020-11-20 | Kayitalire Louis | officer: Chief Medical Officer | 26,437 | A-Award | A | 26,437 | 0.00 | 0.00 |
2021-07-02 | Kayitalire Louis | officer: Chief Medical Officer | 54,383 | S-Sale | D | 1,054 | 8.43 | 8,885.00 |
2021-06-04 | Krol Patrick Johan Hendrik | director | 20,000 | A-Award | A | 20,000 | 6.88 | 137,600.00 |
2021-06-04 | Klein Pamela M. | director | 20,000 | A-Award | A | 20,000 | 6.88 | 137,600.00 |
2021-06-04 | Brady Todd C | director | 20,000 | A-Award | A | 20,000 | 6.88 | 137,600.00 |
2021-06-04 | Bermingham Nessan | director | 20,000 | A-Award | A | 20,000 | 6.88 | 137,600.00 |
2021-06-04 | Race Geoffrey | director | 20,000 | A-Award | A | 20,000 | 6.88 | 137,600.00 |
2021-06-04 | Benz Edward JR | director | 20,000 | A-Award | A | 20,000 | 6.88 | 137,600.00 |
2021-06-04 | Arkowitz David | director | 20,000 | A-Award | A | 20,000 | 6.88 | 137,600.00 |
2021-03-09 | Forster Eliot | director, officer: President and CEO | 388,901 | A-Award | A | 127,924 | 7.24 | 926,170.00 |
2021-03-09 | Brewis Neil | officer: Chief Scientific Officer | 99,180 | A-Award | A | 22,561 | 7.24 | 163,342.00 |
2021-03-09 | DEPTULA-HICKS DARLENE M | officer: Treasurer and CFO | 54,320 | A-Award | A | 25,894 | 7.24 | 187,473.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.